Improving clinical application of quality of life scores in epidermolysis bullosa (EB): Clinical significant outcomes in the QOLEB questionnaire

被引:0
|
作者
Frew, J. W. [1 ]
Murrell, D. F. [1 ,2 ]
机构
[1] St George Hosp, Dept Dermatol, Sydney, NSW, Australia
[2] Univ New S Wales, Sydney, NSW, Australia
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:38 / 38
页数:1
相关论文
共 50 条
  • [21] INFLUENCE OF THE CHANGE OF TREATMENT ON QUALITY OF LIFE OF AN ADULT PATIENT WITH EPIDERMOLYSIS BULLOSA. CLINICAL CASE
    Aguilar Vega, Francisca
    Sanchez Hernandez, Maria Del Mar
    Lopez Perez, Maria Soledad
    REVISTA ROL DE ENFERMERIA, 2016, 39 (04): : 268 - 272
  • [22] Quality of life outcomes of cultured allogeneic fibroblast therapy recipients with epidermolysis bullosa
    Frew, J. W.
    Venugopal, S. S.
    Murrell, D. F.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2011, 52 : 26 - 26
  • [23] IMPROVING PATIENT VERSIONS OF CLINICAL PRACTICE GUIDELINES FOR PEOPLE LIVING WITH EPIDERMOLYSIS BULLOSA
    Mayre-Chilton, Kattya M.
    Mullins, Olivia
    Taguchi, Lie A.
    ACTA DERMATO-VENEREOLOGICA, 2020, 100 : 60 - 60
  • [24] A comparison study of Outcome Measures for Epidermolysis Bullosa; Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)
    Rogers, C.
    Gibson, M.
    Kern, J. S.
    Martin, L. K.
    Robertson, S. J.
    Su, J. C.
    Daniel, B. S.
    Murrell, D. F.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S28 - S28
  • [25] A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)
    Rogers, Clare L.
    Gibson, Matthew
    Kern, Johannes S.
    Martin, Linda K.
    Robertson, Susan J.
    Daniel, Benjamin S.
    Su, John C.
    Murrell, Oliver G. C.
    Feng, Grant
    Murrell, Dedee F.
    JAAD INTERNATIONAL, 2021, 2 : 134 - 152
  • [26] Epidermolysis bullosa and gait analysis: One big step toward improving quality of life
    Bardhan, Ajoy
    James, Lisa
    O'Sullivan, Mark
    Heagerty, Adrian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB132 - AB132
  • [27] Epidermolysis bullosa-specific module of the Infants and Toddlers Dermatology Quality of Life (InToDermQoL) questionnaire
    Chernyshov, P. V.
    Suru, A.
    Gedeon, I.
    Derevyanko, L. A.
    Tiplica, G. S.
    Salavastru, C. M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (03) : 612 - 617
  • [28] Reliability and validity of the instrument for scoring clinical outcomes of research for epidermolysis bullosa (iscorEB)
    Bruckner, A. L.
    Fairclough, D. L.
    Feinstein, J. A.
    Lara-Corrales, I.
    Lucky, A. W.
    Tolar, J.
    Pope, E.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (05) : 1128 - 1134
  • [29] Hindi translation and validation of quality of life score in Indian patients with epidermolysis bullosa; and its correlation with the clinical severity assessment scores: A cross-sectional study
    Bishnoi, Anuradha
    Manjunath, Seema
    Kishore, Kamal
    De, Dipankar
    Handa, Sanjeev
    Murrell, Dedee F.
    Mahajan, Rahul
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2022, 88 (02): : 177 - 183
  • [30] Initial validation of the epidermolysis bullosa-specific module of the Infants and Toddlers Dermatology Quality of Life questionnaire
    Chernyshov, Pavel V.
    Marron, Servando E.
    Tomas-Aragones, Lucia
    Pustisek, Nives
    Gedeon, Inna
    Suru, Alina
    Tiplica, George S.
    Salavastru, Carmen M.
    Nikolic, Milos
    Kakourou, Talia
    Valari, Manthoula
    Yordanova, Ivelina
    Darlenski, Razvigor
    Sampogna, Francesca
    DERMATOLOGIC THERAPY, 2020, 33 (06)